InsidersTradesSigma
达安基因: insider trades · France · AMF
SZSE:002030FR·AMFMcap 8.4Bn€
Discover the full insider trade history of 达安基因, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €8.4bn. The latest transaction was disclosed on 20 December 2021 (Sale). Among the most active insiders: 周新宇. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
6.64 €
Income statement
Revenue757.7 M€
Gross profit245.5 M€32% margin
Net income−744.4 M€-98.2% margin
Balance sheet & cash
Market cap8.36 Bn€
Total debt114.7 M€
Free Cash Flow80.5 M€
Last declaration on 20 December 2021